EASY SYSTEM NG.BIOTECH
LIVE

Serial Number

79302185

Owner

NG BIOTECH

Attorney

Jeffrey H. Handelsman

Filing Date

Nov 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EASY SYSTEM NG.BIOTECH Trademark

Serial Number: 79302185 • Registration: 6914784

EASY SYSTEM NG.BIOTECH is a trademark filed by NG BIOTECH on November 5, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

NG BIOTECH (5 trademarks)

Atelier Relais le Tremplin Guipry
GUIPRY-MESSAC 35480 , FR

Entity Type: 03

Trademark Details

Filing Date

November 5, 2020

Registration Date

December 6, 2022

Published for Opposition

September 20, 2022

Goods & Services

Retail, wholesale and online retail store services for pharmaceutical products, namely, diagnostic and analytical test materials, preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, pharmaceutical preparations, namely, diagnostic and analytical test materials, preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical preparations in the nature of diagnostic and analytical preparations for medical purposes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, sanitary preparations for medical purposes in the nature of diagnostic and analytical preparations for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, analytical tests in the immunoassay field, namely, test strips, test cassettes and midstream test cassettes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical diagnostic tests and reagents for analyzing body fluids, material, preparations and reagents for diagnostic tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical diagnostic test strips for use in testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for rapid diagnostic guidance tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for serological tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for antigen detection tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, chemical reagents for medical use, pregnancy testing preparations and medical diagnostic reagents for pregnancy tests, home pregnancy test kits, medical diagnostic test kits comprised of medical diagnostic reagents for testing of body fluids and body samples for use in disease detection of Covid-19, medical diagnostic home testing kits comprised of medical diagnostic reagents and assays that test for the presence of Covid-19, apparatus and instruments for the recording, transmission, reproduction or processing of data, mobile data communications apparatus, wireless communications devices enabling data transmission, downloadable or recorded media, namely, downloadable or recorded digital files featuring medical data, digital recording media, namely, pre-recorded downloadable audio and video recordings featuring medical data, downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data, computer platforms in the form of recorded or downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data, downloadable software for transmitting and managing data, downloadable application software for wireless devices for transmitting, reading, communicating, analyzing, managing and tracking medical data, downloadable software for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field, downloadable software for scheduling, conducting and monitoring therapeutic follow-up, downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, downloadable software applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, downloadable mobile applications for transmitting and managing data, downloadable mobile applications for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field, downloadable mobile applications for scheduling, conducting and monitoring therapeutic follow-up, downloadable mobile applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, research laboratory analyzers for measuring, testing and analyzing of blood and other bodily fluids, medical apparatus and instruments for reading test results from diagnostic and analytical tests for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical instruments for testing for infectious diseases, namely, biosensors for detecting infectious diseases, medical testing instruments for use in medical diagnosis, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, laboratory apparatus for medical diagnosis, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, apparatus for conducting diagnostic tests for medical use, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, diagnostic apparatus for rapid diagnostic guidance tests, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, diagnostic apparatus for serological testing for infectious diseases and Covid-19 antigens, diagnostic apparatus for testing and detecting infectious diseases and Covid-19 antigens , diagnostic apparatus for testing for pregnancy, diagnostic apparatus for Covid-19 detection tests, medical apparatus for reading of analytical tests, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; commercial business management; commercial administration of the licensing of the goods and services of others; office functions; advertising; online advertising; publication of advertising texts; dissemination of advertisements; dissemination of advertising material, namely, leaflets, flyers, prospectuses, printed matter, brochures, and samples; rental of advertising space and advertising material; rental of advertising time on all means of communication media; direct mail advertising services; presentation of goods on all communication media, for retail purposes; providing commercial shopping information and advice for consumers in the choice of products and services; organization of exhibitions, fairs, events, trade fairs for commercial or advertising purposes; product presentation and demonstration services for commercial or advertising purposes; market study; collection, processing and systematization of data, for humans; data management services for use in debt collection, namely, electronic data collection and on-line claims management; transcription of data; services involving the transcription of statistical data; database management; computer file management; collection, compilation and systemization of information into computer databases; all the aforementioned services in connection with medical and veterinary diagnostic tests; none of the above-mentioned services being related to anesthesia machines

Computerized medical analysis apparatus and instruments for analyzing medical diagnosis testing media to determine the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical instruments for testing for infectious diseases, namely, biosensors for detecting infectious diseases; computerized medical testing instruments for use in medical diagnosis, namely, wireless mobile readers specially adapted for analyzing medical diagnostic test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; laboratory apparatus for medical diagnosis, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; apparatus for conducting diagnostic tests for medical use, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; diagnostic apparatus for rapid diagnostic guidance tests, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; diagnostic apparatus for serological testing for infectious diseases and Covid-19 antigens; diagnostic apparatus for testing and detecting infectious diseases and Covid-19 antigens; diagnostic apparatus for testing for pregnancy; diagnostic apparatus for Covid-19 detection tests; computerized medical analysis apparatus for reading of analytical tests, namely, wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; none of the above-mentioned goods being anesthesia machines or intended for anesthesia machines

Apparatus and instruments for the recording, transmission, reproduction or processing of data; mobile data-communication apparatus; wireless communications devices enabling data transmission; downloadable or recorded media, namely, downloadable or recorded digital multimedia files featuring medical data; digital recording media, namely, prerecorded downloadable audio and video recordings featuring medical data; downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data; computer platforms in the form of recorded or downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data; downloadable software for transmitting and managing data; downloadable application software for wireless devices for transmitting, reading, communicating, analyzing, managing and tracking medical data; downloadable software for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field; downloadable software for scheduling, conducting and monitoring therapeutic follow-up; downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results; downloadable software applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results; downloadable mobile applications for transmitting and managing data; downloadable mobile applications for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field; downloadable mobile applications for scheduling, conducting and monitoring therapeutic follow-up; downloadable mobile applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnosis test results; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; none of the abovementioned goods being anesthesia machines or intended for anesthesia machines

Pharmaceutical products, namely, diagnostic and analytical test materials in the nature of in vitro diagnostic preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; pharmaceutical preparations, namely, diagnostic and analytical test materials in the nature of in vitro diagnostic preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical preparations in the nature of diagnostic preparations for medical purposes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; sanitary preparations for medical purposes in the nature of diagnostic and analytical preparations for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; analytical medical diagnostic test kits in the immunoassay field consisting primarily of medical diagnostic test strips, and also medical devices for obtaining body fluid samples being test cassettes and midstream test cassettes, all for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical diagnostic reagents and assays for testing bodily fluids; material, preparations and reagents for diagnostic tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical diagnostic test strips for use in testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for rapid diagnostic guidance tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for serological tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for antigen detection tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; chemical reagents for medical use; pregnancy testing preparations and medical diagnostic reagents for pregnancy tests; home pregnancy test kits; medical diagnostic test kits comprised of medical diagnostic reagents for testing of body fluids and body samples for use in disease detection of Covid-19; medical diagnostic home testing kits comprised of medical diagnostic reagents and assays that test for the presence of Covid-19; none of the above-mentioned goods being anesthesia machines or intended for anesthesia machines

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 9, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 22, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 21, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 6, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Oct 10, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 27, 2022 ERFR
ASSIGNED TO EXAMINER
Jul 7, 2022 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 4, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 15, 2022 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Feb 15, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Feb 15, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Feb 15, 2022 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 15, 2022 GNFN
FINAL REFUSAL E-MAILED
Feb 15, 2022 GNFR
FINAL REFUSAL WRITTEN
Feb 15, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 20, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 20, 2022 COAR
REFUSAL PROCESSED BY IB
Aug 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 23, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 23, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 14, 2021 REPR